Table 5.
Metabolic outcomes by weeka
| Factor | Units | Week One (N = 423) |
Week Six (N = 396) |
Week 30 (N = 299) |
|||
|---|---|---|---|---|---|---|---|
| Mean ± SD | Min - Max | Mean ± SD | Min - Max | Mean ± SD | Min -Max | ||
| Glucose | (mg/dL) | 108 ± 35b | 67 - 330 | 102 ± 27c | 62 - 264 | 103 ± 29 | 59 - 339 |
| (mmol/L) | 6.0 ± 1.9 | 3.7 - 18.3 | 5.7 ± 1.5 | 3.4 - 14.7 | 5.7 ± 1.6 | 3.3 - 18.8 | |
| Triglycerides | (mg/dL) | 137 ± 81 | 34 - 839 | 107 ± 51 | 34 - 405 | 109 ± 52d | 32 - 331 |
| (mmol/L) | 1.5 ± 0.9 | 0.4 - 9.5 | 1.2 ± 0.6 | 0.4 - 4.6 | 1.2 ± 0.6 | 0.4 - 3.7 | |
| Cholesterol | (mg/dL) | 187 ± 39 | 82 - 307 | 166 ± 36 | 80 - 294 | 179 ± 38d | 93 - 290 |
| (mmol/L) | 4.8 ± 1.0 | 2.1 - 7.9 | 4.3 ± 0.9 | 2.1 - 7.6 | 4.6 ± 1.0 | 2.4 - 7.5 | |
| HDL | (mg/dL) | 51 ± 15 | 24 - 128 | 50 ± 14 | 21 - 110 | 55 ± 16d | 21 - 147 |
| (mmol/L) | 1.3 ± 0.4 | 0.6 - 3.3 | 1.3 ± 0.4 | 0.5 - 2.8 | 1.4 ± 0.4 | 0.5 - 3.8 | |
| LDL | (mg/dL) | 109 ± 33b | 21 - 218 | 95 ± 31 | 17 - 225 | 102 ± 32e | 26 - 215 |
| (mmol/L) | 2.8 ± 0.9 | 0.5 - 5.6 | 2.5 ± 0.8 | 0.4 - 5.8 | 2.6 ± 0.8 | 0.7 - 5.6 | |
| HgbA1c | (%) | 6 ± 1c | 5 - 13 | N/A | N/A | 6 ± 1f | 5 - 10 |
| Insulin | (microU/dL) | 19 ± 18 | 3 - 134 | 14 ± 14 | 1 - 126 | 13 ± 10 | 0.5 - 72 |
| (pmol/L) | 131 ± 122 | 17 - 930 | 97 ± 97 | 7 - 877 | 87 ± 73 | 3.5 - 500 | |
| US-CRP | (mg/mL) | 5 ± 8 | 0.1 - 88 | 4 ± 5 | 0.2 - 33 | 4 ± 6 | 0.2 - 39 |
| (nmol/L) | 45 ± 66 | 0.8 - 740 | 33 ± 45 | 1.7 - 278 | 33 ± 48 | 1.7 - 331 | |
Abbreviations: HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; HgbA1c, hemoglobin A1c; US-CRP, ultra sensitive c-reactive protein. N/A, no required measurement at six weeks.
a N = 271, 266 and 185 for insulin and N = 285, 273 and 201 for US-CRP at weeks 1, 6, and 30, respectively, since neither parameter measured before June 2009;
b, c, d, e, f indicate 3, 28, 7, 2, 1 and 15 missing data points, respectively.